Page last updated: 2024-11-04

coproporphyrinogen iii

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID321
CHEMBL ID1231891
CHEBI ID15439
SCHEMBL ID188419
MeSH IDM0090625

Synonyms (24)

Synonym
5,10,15,20,22,24-hexahydro-3,8,13,17-tetramethyl-2,7,12,18-porphinetetrapropionic acid
CHEMBL1231891
coproporphyrinogen-iii
2,7,12,18-porphinetetrapropionic acid, 5,10,15,20,22,24-hexahydro-3,8,13,17-tetramethyl-
21h,23h-porphine-2,7,12,18-tetrapropanoic acid, 5,10,15,20,22,24-hexahydro-3,8,13,17-tetramethyl-
coproporphyrin iii, hexahydro deriv.
coproporphyrinogen
3,8,13,17-tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,18-tetrapropanoic acid
5,10,15,20,22,24-hexahydro-3,8,13,17-tetramethyl-21h,23h-porphine-2,7,12,18-tetrapropanoic acid
3,8,13,17-tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,18-tetrapropionic acid
CHEBI:15439 ,
C03263
2624-63-7
coproporphyrinogen iii
DB04461
3-[8,12,17-tris(2-carboxyethyl)-3,7,13,18-tetramethyl-5,10,15,20,21,22,23,24-octahydroporphyrin-2-yl]propanoic acid
SCHEMBL188419
DTXSID40180875
3-[9,14,20-tris(2-carboxyethyl)-5,10,15,19-tetramethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1(20),3,5,8,10,13,15,18-octaen-4-yl]propanoic acid
NIUVHXTXUXOFEB-UHFFFAOYSA-N
5,10,15,20,22,24-hexahydro-3,8,13,17-tetramethyl-21h,23h-porphine-2,7,12,18-tetrapropanoate
5,10,15,20,22,24-hexahydro-3,8,13,17-tetramethyl-2,7,12,18-porphinetetrapropionate
3,3',3'',3'''-(3,8,13,17-tetramethyl-5,10,15,20,22,24-hexahydroporphyrin-2,7,12,18-tetrayl)tetrapropanoic acid
Q2468481
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
coproporphyrinogen
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (13)

PathwayProteinsCompounds
Metabolism14961108
Porphyrin metabolism2344
Heme biosynthesis1530
Porphyrin Metabolism1636
Acute Intermittent Porphyria1636
Porphyria Variegata (PV)1636
Congenital Erythropoietic Porphyria (CEP) or Gunther Disease1636
Hereditary Coproporphyria (HCP)1636
Porphyrin_metabolism ( Porphyrin metabolism )716
HMOX1 pathway (COVID-19 Disease Map)3630
Hemesynthesis defects and porphyrias018
heme biosynthesis from uroporphyrinogen-III II012
Biochemical pathways: part I0466
Heme synthesis324

Protein Targets (1)

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (5)

Processvia Protein(s)Taxonomy
protoporphyrinogen IX biosynthetic processOxygen-dependent coproporphyrinogen-III oxidase, mitochondrialHomo sapiens (human)
heme biosynthetic processOxygen-dependent coproporphyrinogen-III oxidase, mitochondrialHomo sapiens (human)
heme A biosynthetic processOxygen-dependent coproporphyrinogen-III oxidase, mitochondrialHomo sapiens (human)
heme B biosynthetic processOxygen-dependent coproporphyrinogen-III oxidase, mitochondrialHomo sapiens (human)
heme O biosynthetic processOxygen-dependent coproporphyrinogen-III oxidase, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (3)

Processvia Protein(s)Taxonomy
coproporphyrinogen oxidase activityOxygen-dependent coproporphyrinogen-III oxidase, mitochondrialHomo sapiens (human)
structural constituent of eye lensOxygen-dependent coproporphyrinogen-III oxidase, mitochondrialHomo sapiens (human)
protein homodimerization activityOxygen-dependent coproporphyrinogen-III oxidase, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (5)

Processvia Protein(s)Taxonomy
mitochondrionOxygen-dependent coproporphyrinogen-III oxidase, mitochondrialHomo sapiens (human)
mitochondrial intermembrane spaceOxygen-dependent coproporphyrinogen-III oxidase, mitochondrialHomo sapiens (human)
cytosolOxygen-dependent coproporphyrinogen-III oxidase, mitochondrialHomo sapiens (human)
membraneOxygen-dependent coproporphyrinogen-III oxidase, mitochondrialHomo sapiens (human)
cytoplasmOxygen-dependent coproporphyrinogen-III oxidase, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID574831Activity at recombinant human CPO2011Bioorganic & medicinal chemistry, Feb-15, Volume: 19, Issue:4
Normal and abnormal heme biosynthesis. Part 7. Synthesis and metabolism of coproporphyrinogen-III analogues with acetate or butyrate side chains on rings C and D. Development of a modified model for the active site of coproporphyrinogen oxidase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.78)18.7374
1990's12 (33.33)18.2507
2000's13 (36.11)29.6817
2010's9 (25.00)24.3611
2020's1 (2.78)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 45.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index45.09 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index5.55 (4.65)
Search Engine Demand Index58.12 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (45.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.78%)6.00%
Case Studies1 (2.78%)4.05%
Observational0 (0.00%)0.25%
Other34 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]